Treatment · May 27, 2026
FDA Approves First Ever Treatment for Hepatitis D in the United States
FDA approves Hepcludex as the first-ever treatment for hepatitis D, offering hope to patients with limited options....
Research · May 26, 2026
Liver Organoids From iPS Cells Show Promise for Transplant Alternatives
Japanese iPS organoid research is driving significant advances in regenerative medicine....
Research · April 20, 2026
Researchers Reverse Fatty Liver Disease in Mice by Targeting Inflammatory Immune Cells
UCLA researchers discover method to reverse chronic disease without requiring dietary changes....